HARTMANN GUNTHER has a total of 24 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BIOGNOSTIK GES, SACKSTEIN ROBERT and BIOGENERA S P A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Mechanical elements | |
#6 | Measurement | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Climate change adaptation technologies | |
#6 | Nails | |
#7 | Analysing materials | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hartmann Gunther | 21 |
#2 | Hornung Veit | 12 |
#3 | Barchet Winfried | 4 |
#4 | Wimmenauer Vera | 4 |
#5 | Schlee Martin | 3 |
#6 | Hornung Veit Dr | 2 |
#7 | De Fougerolles Antonin | 1 |
#8 | Endres Stefan | 1 |
Publication | Filing date | Title |
---|---|---|
US2011250175A1 | TLR7 ligand and uses thereof | |
US2011184045A1 | Silencng and rig-i activation by dual function oligonucleotides | |
EP2297323A1 | 5' triphosphate oligonucleotide with blunt end and uses thereof | |
EP2338499A1 | 5' triphosphate oligonucleotide induces anti-viral response | |
EP1924284A1 | Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides | |
EP1764107A1 | Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides | |
EP1764108A1 | Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides |